Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
This senolytic peptide disrupts the FOXO4-p53 interaction that maintains senescent cell viability
[PMID: 6085417] PubMed record related to this compound for laboratory literature review
Some research has shown that even in the absence of functional beta-3 receptors, acute AOD-9604 administration still increased energy expenditure and fat oxidation, suggesting the peptide may influence brown fat or thermogenic pathways through additional mechanisms
PubMed Rosenstock, J., Frias, J., Jastreboff, A.M., Du, Y., Lou, J., Gurbuz, S., et al
US$ 24.07
US$ 25.51
US$ 20.35
